StockData
Guided Therapeutics Inc logo

Guided Therapeutics Inc (GTHP) stock

GTHPOTCElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 4/30
$0.16−0.03 (-15.79%)

Close on Oct 19, 2026Market cap $15.45MP/E –Yield –

Guided Therapeutics ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

Guided Therapeutics's ebitda for the twelve months ending Dec 31, 2020 was -$1.05M. For fiscal 2020 it was -$1.05M. The highest annual figure on record is -$916.00K in fiscal 2019.

Annual ebitda

PeriodPeriod endValueChange
FY2020Dec 31, 2020-$1.05M–
FY2019Dec 31, 2019-$916.00K–
FY2018Dec 31, 2018-$1.52M–
FY2017Dec 31, 2017-$2.91M–
FY2016Dec 31, 2016-$2.60M–
FY2015Dec 31, 2015-$5.17M–
FY2014Dec 31, 2014-$7.43M–
FY2013Dec 31, 2013-$6.15M–
FY2012Dec 31, 2012-$3.92M–
FY2011Dec 31, 2011-$6.72M–

Quarterly ebitda

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2020Dec 31, 2020-$288.00K–
Q3 FY2020Sep 30, 2020-$153.00K–
Q2 FY2020Jun 30, 2020-$369.00K–
Q1 FY2020Mar 31, 2020-$242.00K–
Q4 FY2019Dec 31, 2019-$165.00K–
Q3 FY2019Sep 30, 2019-$188.00K–
Q2 FY2019Jun 30, 2019-$311.00K–
Q1 FY2019Mar 31, 2019-$252.00K–
Q4 FY2018Dec 31, 2018-$444.00K–
Q3 FY2018Sep 30, 2018-$229.00K–
Q2 FY2018Jun 30, 2018-$480.00K–
Q1 FY2018Mar 31, 2018-$370.00K–
Q4 FY2017Dec 31, 2017-$595.00K–
Q3 FY2017Sep 30, 2017-$1.32M–
Q2 FY2017Jun 30, 2017-$510.00K–
Q1 FY2017Mar 31, 2017-$477.00K–
Q4 FY2016Dec 31, 2016-$39.00K–
Q3 FY2016Sep 30, 2016-$633.00K–

More Guided Therapeutics figures

See a number that looks wrong?